Cytosorbents (CTSO) Raw Materials (2023 - 2026)

Cytosorbents has reported Raw Materials for 4 years, with the latest figure at $552000.0 in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials rose 0.95% year-over-year to $552000.0; the trailing twelve-month figure through Mar 2026 stood at $552000.0 (up 0.95% YoY), and the FY2025 full-year result was $751000.0, up 31.75% from the prior year.
• Raw Materials for Q1 2026 stood at $552000.0, down from $751000.0 in the prior quarter.
• The five-year high for Raw Materials was $751000.0 in Q4 2025, with the low at $491000.0 in Q2 2025.
• Historically, Raw Materials has averaged $594515.1 across 4 years, with a median of $565000.0 in 2025.
• Annual changes were most pronounced in 2024 — Raw Materials decreased 16.89% — and 2025, when it jumped 31.75%.
• Cytosorbents' Raw Materials stood at $685801.0 in 2023, then declined by 16.89% to $570000.0 in 2024, then soared by 31.75% to $751000.0 in 2025, then declined by 26.5% to $552000.0 in 2026.
• The last three Raw Materials figures came in at $552000.0 (Q1 2026), $751000.0 (Q4 2025), and $565000.0 (Q3 2025), per Business Quant data.